FOXL2 and granulosa cell tumor: Well over 90% of ovarian adult granulosa cell tumours harbour a recurrent gain‐of‐function FOXL2 mutation (p.C134W), and tumours that lack this alteration can often be re‐classified upon re‐review of their histopathologic features.95, 96, 97, 98